Database Query Results : , , RAS

RAS, RAS: Click to Expand ⟱
Source: CGL-CS
Type:
Family of RAS proteins (KRAS, NRAS, and HRAS) have been well described to cause oncogenic transformation.

- The expression and mutational status of RAS isoforms are critical in several cancers and are generally linked with a poorer prognosis when mutated.
Scientific Papers found: Click to Expand⟱
2674- BBR,    Berberine: A novel therapeutic strategy for cancer
- Review, Var, NA - Review, IBD, NA
Inflam↓, AntiCan↑, Apoptosis↑, TumAuto↑, TumCCA↑, TumMeta↓, TumCI↓, eff↑, eff↑, CD4+↓, TNF-α↓, IL1↓, BioAv↓, BioAv↓, other↓, AMPK↑, MAPK↓, NF-kB↓, IL6↓, MCP1↓, PGE2↓, COX2↓, *ROS↓, *antiOx↑, *GPx↑, *Catalase↑, AntiTum↑, TumCP↓, angioG↓, Fas↑, FasL↑, ROS↑, ATM↑, P53↑, RB1↑, Casp9↑, Casp8↑, Casp3↓, BAX↑, Bcl-2↓, Bcl-xL↓, IAP1↓, XIAP↓, survivin↓, MMP2↓, MMP9↓, CycB↓, CDC25↓, CDC25↓, Cyt‑c↑, MMP↓, RenoP↑, mTOR↓, MDM2↓, LC3II↑, ERK↓, COX2↓, MMP3↓, TGF-β↓, EMT↑, ROCK1↓, FAK↓, RAS↓, Rho↓, NF-kB↓, uPA↓, MMP1↓, MMP13↓, ChemoSen↑,
2762- BetA,    Targeting Effect of Betulinic Acid Liposome Modified by Hyaluronic Acid on Hepatoma Cells In Vitro
- in-vitro, Liver, HepG2
ROCK1↓, RAS↓, *BioAv↓, BioAv↑,
424- CUR,    Curcumin inhibits autocrine growth hormone-mediated invasion and metastasis by targeting NF-κB signaling and polyamine metabolism in breast cancer cells
- in-vitro, BC, MCF-7 - in-vitro, BC, MDA-MB-231
Src↓, p‑STAT1↓, p‑Akt↓, p‑p44↓, p‑p42↓, RAS↓, Raf↓, Vim↓, β-catenin/ZEB1↓, P53↓, Bcl-2↓, Mcl-1↓, PIAS-3↑, SOCS-3↑, SOCS1↑, ROS↑, NF-kB↓, PAO↑, SSAT↑, P21↑, Bak↑,
1854- dietFMD,    How Far Are We from Prescribing Fasting as Anticancer Medicine?
- Review, Var, NA
ChemoSideEff↓, ChemoSen↑, IGF-1↓, IGFBP1↑, adiP↑, glyC↓, E-cadherin↑, MMPs↓, Casp3↑, ROS↑, ATP↓, AMPK↑, mTOR↓, ROS↑, Glycolysis↓, NADPH↓, OXPHOS↝, eff↑, eff↑, *RAS↓, *MAPK↓, *PI3K↓, *Akt↓, eff↑, ROS↑, Akt↑, Casp3↑,
649- EGCG,  CUR,  PI,    Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets
- Review, Var, NA
*BioEnh↑, EGFR↓, HER2/EBBR2↓, IGF-1↓, MAPK↓, ERK↓, RAS↓, Raf↓, NF-kB↓, p‑pRB↓, TumCCA↑, Glycolysis↓, Warburg↓, HK2↓, Pyruv↓,
2827- FIS,    The Potential Role of Fisetin, a Flavonoid in Cancer Prevention and Treatment
- Review, Var, NA
*antiOx↑, *Inflam↓, neuroP↑, hepatoP↑, RenoP↑, cycD1↓, TumCCA↑, MMPs↓, VEGF↓, MAPK↓, NF-kB↓, angioG↓, Beclin-1↑, LC3s↑, ATG5↑, Bcl-2↓, BAX↑, Casp↑, TNF-α↓, Half-Life↓, MMP↓, mt-ROS↑, cl‑PARP↑, CDK2↓, CDK4↓, Cyt‑c↑, Diablo↑, DR5↑, Fas↑, PCNA↓, Ki-67↓, p‑H3↓, chemoP↑, Ca+2↑, Dose↝, CDC25↓, CDC2↓, CHK1↑, Chk2↑, ATM↑, PCK1↓, RAS↓, p‑p38↓, Rho↓, uPA↓, MMP7↓, MMP13↓, GSK‐3β↑, E-cadherin↑, survivin↓, VEGFR2↓, IAP2↓, STAT3↓, JAK1↓, mTORC1↓, mTORC2↓, NRF2↑,
2894- HNK,    Pharmacological features, health benefits and clinical implications of honokiol
- Review, Var, NA - Review, AD, NA
*BioAv↓, *neuroP↑, *BBB↑, *ROS↓, *Keap1↑, *NRF2↑, *Casp3↓, *SIRT3↑, *Rho↓, *ERK↓, *NF-kB↓, angioG↓, RAS↓, PI3K↓, Akt↓, mTOR↓, *memory↑, *Aβ↓, *PPARγ↑, *PGC-1α↑, NF-kB↓, Hif1a↓, VEGF↓, HO-1↓, Foxm1↓, p27↑, P21↑, CDK2↓, CDK4↓, CDK6↓, cycD1↓, Twist↓, MMP2↓, Rho↑, ROCK1↑, TumCMig↓, cFLIP↓, BMPs↑, OCR↑, ECAR↓, *AntiAg↑, *cardioP↑, *antiOx↑, *ROS↓, P-gp↓,
2883- HNK,    Honokiol targets mitochondria to halt cancer progression and metastasis
- Review, Var, NA
ChemoSen↑, BBB↓, Ca+2↑, Cyt‑c↑, Casp3↑, chemoP↑, OCR↓, mitResp↓, Apoptosis↑, RadioS↑, NF-kB↓, Akt↓, TNF-α↓, PGE2↓, VEGF↓, NO↝, COX2↓, RAS↓, EMT↓, Snail↓, N-cadherin↓, β-catenin/ZEB1↓, E-cadherin↑, ER Stress↑, p‑STAT3↓, EGFR↓, mTOR↓, mt-ROS↑, PI3K↓, Wnt↓,
2885- HNK,    Honokiol: a novel natural agent for cancer prevention and therapy
NF-kB↓, STAT3↓, EGFR↓, mTOR↓, BioAv↝, Inflam↓, TumCP↓, angioG↓, TumCI↓, TumMeta↓, cSrc↓, JAK1↓, JAK2↓, ERK↓, Akt↓, PTEN↑, ChemoSen↑, chemoP↑, COX2↓, PGE2↓, TNF-α↓, IL1β↓, IL6↓, Casp3↑, Casp8↑, Casp9↑, cl‑PARP↑, DNAdam↑, Cyt‑c↑, RadioS↑, RAS↓, BBB↑, BioAv↓, Half-Life↝, Half-Life↝, toxicity↓,
2914- LT,    Therapeutic Potential of Luteolin on Cancer
- Review, Var, NA
*antiOx↑, *IronCh↑, *toxicity↓, *BioAv↓, *BioAv↑, DNAdam↑, TumCP↓, DR5↑, P53↑, JNK↑, BAX↑, cl‑Casp3↑, cl‑Casp8↑, cl‑Casp9↑, cl‑PARP↑, survivin↓, cycD1↓, CycB↓, CDC2↓, P21↑, angioG↓, MMP2↓, AEG1↓, VEGF↓, VEGFR2↓, MMP9↓, CXCR4↓, PI3K↓, Akt↓, ERK↓, TumAuto↑, LC3B-II↑, EMT↓, E-cadherin↑, N-cadherin↓, Wnt↓, ROS↑, NICD↓, p‑GSK‐3β↓, iNOS↓, COX2↓, NRF2↑, Ca+2↑, ChemoSen↑, ChemoSen↓, IFN-γ↓, RadioS↑, MDM2↓, NOTCH1↓, AR↓, TIMP1↑, TIMP2↑, ER Stress↑, CDK2↓, Telomerase↓, p‑NF-kB↑, p‑cMyc↑, hTERT↓, RAS↓, YAP/TEAD↓, TAZ↓, NF-kB↓, NRF2↓, HO-1↓, MDR1↓,
1807- NarG,    A Systematic Review of the Preventive and Therapeutic Effects of Naringin Against Human Malignancies
- Review, NA, NA
AntiTum↑, TumCP↓, tumCV↓, TumCCA↑, Mcl-1↓, RAS↓, e-Raf↓, VEGF↓, AntiAg↑, MMP2↓, MMP9↓, TIMP2↑, TIMP1↑, p38↓, Wnt↓, β-catenin/ZEB1↑, Casp↑, P53↑, BAX↑, COX2↓, GLO-I↓, CYP1A1↑, lipid-P↓, p‑Akt↓, p‑mTOR↓, VCAM-1↓, P-gp↓, survivin↓, Bcl-2↓, ROS↑, ROS↑, MAPK↑, STAT3↓, chemoP↑,
2946- PL,    Piperlongumine, a potent anticancer phytotherapeutic: Perspectives on contemporary status and future possibilities as an anticancer agent
- Review, Var, NA
ROS↑, GSH↓, DNAdam↑, ChemoSen↑, RadioS↑, BioEnh↑, selectivity↑, BioAv↓, eff↑, p‑Akt↓, mTOR↓, GSK‐3β↓, β-catenin/ZEB1↓, HK2↓, Glycolysis↓, Cyt‑c↑, Casp9↑, Casp3↑, Casp7↑, cl‑PARP↑, TrxR↓, ER Stress↑, ATF4↝, CHOP↑, Prx4↑, NF-kB↓, cycD1↓, CDK4↓, CDK6↓, p‑RB1↓, RAS↓, cMyc↓, TumCCA↑, selectivity↑, STAT3↓, NRF2↑, HO-1↑, PTEN↑, P-gp↓, MDR1↓, MRP1↓, survivin↓, Twist↓, AP-1↓, Sp1/3/4↓, STAT1↓, STAT6↓, SOX4↑, XBP-1↑, P21↑, eff↑, Inflam↓, COX2↓, IL6↓, MMP9↓, TumMeta↓, TumCI↓, ICAM-1↓, CXCR4↓, VEGF↓, angioG↓, Half-Life↝, BioAv↑,
3352- QC,    A review of quercetin: Antioxidant and anticancer properties
- Review, Var, NA
*antiOx↑, *lipid-P↓, *TNF-α↓, *NF-kB↓, *COX2↓, *IronCh↑, P53↓, TumCCA↑, HSPs↓, P21↓, RAS↓, ER(estro)↑, OS?,
3350- QC,    Quercetin and the mitochondria: A mechanistic view
- Review, NA, NA
*antiOx↑, *Inflam↓, *NRF2↑, ROS⇅, *NRF2↑, *HO-1↑, *PPARα↑, *PGC-1α↑, *SIRT1↑, *ATP↑, ATP↓, ERK↓, cl‑PARP↑, Casp9↑, Casp8↑, BAX↑, MMP↓, Cyt‑c↑, Casp3↑, HSP27↓, HSP72↓, RAS↓, Raf↓,
3343- QC,    Quercetin, a Flavonoid with Great Pharmacological Capacity
- Review, Var, NA - Review, AD, NA - Review, Arthritis, NA
*antiOx↑, *ROS↓, *angioG↓, *Inflam↓, *BioAv↓, *Half-Life↑, *GSH↑, *SOD↑, *Catalase↑, *Nrf1↑, *BP↓, *cardioP↑, *IL10↓, *TNF-α↓, *Aβ↓, *GSK‐3β↓, *tau↓, *neuroP↑, *Pain↓, *COX2↓, *NRF2↑, *HO-1↑, *IL1β↓, *IL17↓, *MCP1↓, PKCδ↓, ERK↓, BAX↓, cMyc↓, KRAS↓, ROS↓, selectivity↑, tumCV↓, Apoptosis↑, TumCCA↑, eff↑, P-gp↓, eff↑, eff↑, eff↑, eff↑, CycB↓, CDK1↓, CDK4↓, CDK2↓, TOP2↓, Cyt‑c↑, cl‑PARP↑, MMP↓, HSP70/HSPA5↓, HSP90↓, MDM2↓, RAS↓, eff↑,
3372- QC,  FIS,  KaempF,    Anticancer Potential of Selected Flavonols: Fisetin, Kaempferol, and Quercetin on Head and Neck Cancers
- Review, HNSCC, NA
ROCK1↑, TumCCA↓, HSPs↓, RAS↓, ROS↑, Ca+2↑, MMP↓, Cyt‑c↑, Endon↑, MMP9↓, MMP2↓, MMP7↓, MMP-10↓, VEGF↓, NF-kB↓, p65↓, iNOS↓, COX2↓, uPA↓, PI3K↓, FAK↓, MEK↓, ERK↓, JNK↓, p38↓, cJun↓, FOXO3↑,
3369- QC,    Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects
- Review, Pca, NA
FAK↓, TumCCA↑, p‑pRB↓, CDK2↑, CycB↓, CDK1↓, EMT↓, PI3K↓, MAPK↓, Wnt↓, ROS↑, miR-21↑, Akt↓, NF-kB↓, FasL↑, Bak↑, BAX↑, Bcl-2↓, Casp3↓, Casp9↑, P53↑, p38↑, MAPK↑, Cyt‑c↑, PARP↓, CHOP↑, ROS↓, LDH↑, GRP78/BiP↑, ERK↑, MDA↓, SOD↑, GSH↑, NRF2↑, VEGF↓, PDGF↓, EGF↓, FGF↓, TNF-α↓, TGF-β↓, VEGFR2↓, EGFR↓, FGFR1↓, mTOR↓, cMyc↓, MMPs↓, LC3B-II↑, Beclin-1↑, IL1β↓, CRP↓, IL10↓, COX2↓, IL6↓, TLR4↓, Shh↓, HER2/EBBR2↓, NOTCH↓, DR5↑, HSP70/HSPA5↓, CSCs↓, angioG↓, MMP2↓, MMP9↓, IGFBP3↑, uPA↓, uPAR↓, RAS↓, Raf↓, TSP-1↑,
3083- RES,    Resveratrol suppresses breast cancer cell invasion by inactivating a RhoA/YAP signaling axis
- in-vitro, BC, MDA-MB-231 - in-vitro, BC, MDA-MB-468
YAP/TEAD↓, Rho↓, FAK↓, MMP9↓, ChemoSen↑, RAS↓, ROCK1↓, TumCI↓, TumMeta↓,
2127- TQ,    Therapeutic Potential of Thymoquinone in Glioblastoma Treatment: Targeting Major Gliomagenesis Signaling Pathways
- Review, GBM, NA
chemoP↑, ChemoSen↑, BioAv↑, PTEN↑, PI3K↓, Akt↓, TumCCA↓, NF-kB↓, p‑Akt↓, p65↓, XIAP↓, Bcl-2↓, COX2↓, VEGF↓, mTOR↓, RAS↓, Raf↓, MEK↓, ERK↓, MMP2↓, MMP9↓, TumCMig↓, TumCI↓, Casp↑, cl‑PARP↑, ROS⇅, ROS↑, MMP↓, eff↑, Telomerase↓, DNAdam↑, Apoptosis↑, STAT3↓, RadioS↑,
1817- VitK2,    Research progress on the anticancer effects of vitamin K2
- Review, Var, NA
TumCCA↑, Apoptosis↑, TumAuto↑, TumCI↓, TumCG↓, ChemoSen↓, ChemoSideEff↓, toxicity∅, eff↑, cycD1↓, CDK4↓, eff↑, IKKα↓, NF-kB↓, other↑, p27↑, cMyc↓, i-ROS↑, Bcl-2↓, BAX↑, p38↑, MMP↓, Casp9↑, p‑ERK↓, RAS↓, MAPK↓, p‑P53↑, Casp8↑, Casp3↑, cJun↑, MMPs↓, eff↑, eff↑,

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 20

Results for Effect on Cancer/Diseased Cells:
adiP↑,1,   AEG1↓,1,   Akt↓,6,   Akt↑,1,   p‑Akt↓,4,   AMPK↑,2,   angioG↓,7,   AntiAg↑,1,   AntiCan↑,1,   AntiTum↑,2,   AP-1↓,1,   Apoptosis↑,5,   AR↓,1,   ATF4↝,1,   ATG5↑,1,   ATM↑,2,   ATP↓,2,   Bak↑,2,   BAX↓,1,   BAX↑,7,   BBB↓,1,   BBB↑,1,   Bcl-2↓,7,   Bcl-xL↓,1,   Beclin-1↑,2,   BioAv↓,4,   BioAv↑,3,   BioAv↝,1,   BioEnh↑,1,   BMPs↑,1,   Ca+2↑,4,   Casp↑,3,   Casp3↓,2,   Casp3↑,7,   cl‑Casp3↑,1,   Casp7↑,1,   Casp8↑,4,   cl‑Casp8↑,1,   Casp9↑,6,   cl‑Casp9↑,1,   CD4+↓,1,   CDC2↓,2,   CDC25↓,3,   CDK1↓,2,   CDK2↓,4,   CDK2↑,1,   CDK4↓,5,   CDK6↓,2,   cFLIP↓,1,   chemoP↑,5,   ChemoSen↓,2,   ChemoSen↑,8,   ChemoSideEff↓,2,   CHK1↑,1,   Chk2↑,1,   CHOP↑,2,   cJun↓,1,   cJun↑,1,   cMyc↓,4,   p‑cMyc↑,1,   COX2↓,10,   CRP↓,1,   CSCs↓,1,   cSrc↓,1,   CXCR4↓,2,   CycB↓,4,   cycD1↓,5,   CYP1A1↑,1,   Cyt‑c↑,9,   Diablo↑,1,   DNAdam↑,4,   Dose↝,1,   DR5↑,3,   E-cadherin↑,4,   ECAR↓,1,   eff↑,18,   EGF↓,1,   EGFR↓,4,   EMT↓,3,   EMT↑,1,   Endon↑,1,   ER Stress↑,3,   ER(estro)↑,1,   ERK↓,8,   ERK↑,1,   p‑ERK↓,1,   FAK↓,4,   Fas↑,2,   FasL↑,2,   FGF↓,1,   FGFR1↓,1,   Foxm1↓,1,   FOXO3↑,1,   GLO-I↓,1,   glyC↓,1,   Glycolysis↓,3,   GRP78/BiP↑,1,   GSH↓,1,   GSH↑,1,   GSK‐3β↓,1,   GSK‐3β↑,1,   p‑GSK‐3β↓,1,   p‑H3↓,1,   Half-Life↓,1,   Half-Life↝,3,   hepatoP↑,1,   HER2/EBBR2↓,2,   Hif1a↓,1,   HK2↓,2,   HO-1↓,2,   HO-1↑,1,   HSP27↓,1,   HSP70/HSPA5↓,2,   HSP72↓,1,   HSP90↓,1,   HSPs↓,2,   hTERT↓,1,   IAP1↓,1,   IAP2↓,1,   ICAM-1↓,1,   IFN-γ↓,1,   IGF-1↓,2,   IGFBP1↑,1,   IGFBP3↑,1,   IKKα↓,1,   IL1↓,1,   IL10↓,1,   IL1β↓,2,   IL6↓,4,   Inflam↓,3,   iNOS↓,2,   JAK1↓,2,   JAK2↓,1,   JNK↓,1,   JNK↑,1,   Ki-67↓,1,   KRAS↓,1,   LC3B-II↑,2,   LC3II↑,1,   LC3s↑,1,   LDH↑,1,   lipid-P↓,1,   MAPK↓,5,   MAPK↑,2,   Mcl-1↓,2,   MCP1↓,1,   MDA↓,1,   MDM2↓,3,   MDR1↓,2,   MEK↓,2,   miR-21↑,1,   mitResp↓,1,   MMP↓,7,   MMP-10↓,1,   MMP1↓,1,   MMP13↓,2,   MMP2↓,7,   MMP3↓,1,   MMP7↓,2,   MMP9↓,8,   MMPs↓,4,   MRP1↓,1,   mTOR↓,8,   p‑mTOR↓,1,   mTORC1↓,1,   mTORC2↓,1,   N-cadherin↓,2,   NADPH↓,1,   neuroP↑,1,   NF-kB↓,14,   p‑NF-kB↑,1,   NICD↓,1,   NO↝,1,   NOTCH↓,1,   NOTCH1↓,1,   NRF2↓,1,   NRF2↑,4,   OCR↓,1,   OCR↑,1,   OS?,1,   other↓,1,   other↑,1,   OXPHOS↝,1,   P-gp↓,4,   P21↓,1,   P21↑,4,   p27↑,2,   p38↓,2,   p38↑,2,   p‑p38↓,1,   p‑p42↓,1,   p‑p44↓,1,   P53↓,2,   P53↑,4,   p‑P53↑,1,   p65↓,2,   PAO↑,1,   PARP↓,1,   cl‑PARP↑,7,   PCK1↓,1,   PCNA↓,1,   PDGF↓,1,   PGE2↓,3,   PI3K↓,6,   PIAS-3↑,1,   PKCδ↓,1,   p‑pRB↓,2,   Prx4↑,1,   PTEN↑,3,   Pyruv↓,1,   RadioS↑,5,   Raf↓,5,   e-Raf↓,1,   RAS↓,19,   RB1↑,1,   p‑RB1↓,1,   RenoP↑,2,   Rho↓,3,   Rho↑,1,   ROCK1↓,3,   ROCK1↑,2,   ROS↓,2,   ROS↑,12,   ROS⇅,2,   i-ROS↑,1,   mt-ROS↑,2,   selectivity↑,3,   Shh↓,1,   Snail↓,1,   SOCS-3↑,1,   SOCS1↑,1,   SOD↑,1,   SOX4↑,1,   Sp1/3/4↓,1,   Src↓,1,   SSAT↑,1,   STAT1↓,1,   p‑STAT1↓,1,   STAT3↓,5,   p‑STAT3↓,1,   STAT6↓,1,   survivin↓,5,   TAZ↓,1,   Telomerase↓,2,   TGF-β↓,2,   TIMP1↑,2,   TIMP2↑,2,   TLR4↓,1,   TNF-α↓,5,   TOP2↓,1,   toxicity↓,1,   toxicity∅,1,   TrxR↓,1,   TSP-1↑,1,   TumAuto↑,3,   TumCCA↓,2,   TumCCA↑,9,   TumCG↓,1,   TumCI↓,6,   TumCMig↓,2,   TumCP↓,4,   tumCV↓,2,   TumMeta↓,4,   Twist↓,2,   uPA↓,4,   uPAR↓,1,   VCAM-1↓,1,   VEGF↓,9,   VEGFR2↓,3,   Vim↓,1,   Warburg↓,1,   Wnt↓,4,   XBP-1↑,1,   XIAP↓,2,   YAP/TEAD↓,2,   β-catenin/ZEB1↓,3,   β-catenin/ZEB1↑,1,  
Total Targets: 277

Results for Effect on Normal Cells:
Akt↓,1,   angioG↓,1,   AntiAg↑,1,   antiOx↑,7,   ATP↑,1,   Aβ↓,2,   BBB↑,1,   BioAv↓,4,   BioAv↑,1,   BioEnh↑,1,   BP↓,1,   cardioP↑,2,   Casp3↓,1,   Catalase↑,2,   COX2↓,2,   ERK↓,1,   GPx↑,1,   GSH↑,1,   GSK‐3β↓,1,   Half-Life↑,1,   HO-1↑,2,   IL10↓,1,   IL17↓,1,   IL1β↓,1,   Inflam↓,3,   IronCh↑,2,   Keap1↑,1,   lipid-P↓,1,   MAPK↓,1,   MCP1↓,1,   memory↑,1,   neuroP↑,2,   NF-kB↓,2,   Nrf1↑,1,   NRF2↑,4,   Pain↓,1,   PGC-1α↑,2,   PI3K↓,1,   PPARα↑,1,   PPARγ↑,1,   RAS↓,1,   Rho↓,1,   ROS↓,4,   SIRT1↑,1,   SIRT3↑,1,   SOD↑,1,   tau↓,1,   TNF-α↓,2,   toxicity↓,1,  
Total Targets: 49

Scientific Paper Hit Count for: RAS, RAS
5 Quercetin
3 Honokiol
2 Curcumin
2 Fisetin
1 Berberine
1 Betulinic acid
1 diet FMD Fasting Mimicking Diet
1 EGCG (Epigallocatechin Gallate)
1 Piperine
1 Luteolin
1 Naringin
1 Piperlongumine
1 Kaempferol
1 Resveratrol
1 Thymoquinone
1 Vitamin K2
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:1  prod#:%  Target#:269  State#:0  Dir#:1
  wNotes=0  sortOrder:rid,rpid

 

Home Page